Biotech ETFs Pop Amid Pending J&J Vaccine Approval
South Africa in the news: Biotech ETFs Pop Amid Pending J&J Vaccine Approval: Biotech ETFs are climbing Wednesday as the Food and Drug Administration’s staff endorsed Johnson & Johnson’s coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.: “South Africa” – BingNews FDA panel to review Johnson & …
